Chronic myeloid leukemia patients’ adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians

References

• GoldmanJMMeloJVChronic myeloid leukemia – advances in biology and new approaches to treatmentN Engl J Med2003349151451146414534339
   PubMed Web of Science ®Google Scholar
• WhitePWalkerPChronic leukemiasSkeelRHandbook of Cancer Chemotherapy7th edPhiladelphia, PALippincott Williams and Wilkins2007497516
   Google Scholar
• GaterAHeronLAbetz-WebbLAdherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemiaLeuk Res201236781782522364811
   PubMed Web of Science ®Google Scholar
• WetzlerMByrdJCBloomfieldCDAcute and chronic myeloid leukemiaKasperDLBraunwaldEHauserSLongoDJamesonJLFauciASHarrison’s Principles of Internal Medicine16th edNew York, NYMcGraw-Hill Companies, Inc.2005631641
   Google Scholar
• DrukerBJGuilhotFO’BrienSGIRIS InvestigatorsFive-year follow-up of patients receiving imatinib for chronic myeloid leukemiaN Engl J Med2006355232408241717151364
   PubMed Web of Science ®Google Scholar
• HochhausAO’BrienSGGuilhotFIRIS InvestigatorsSix-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemiaLeukemia20092361054106119282833
   PubMed Web of Science ®Google Scholar
• MarinDBazeosAMahonFXAdherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinibJ Clin Oncol201028142381238820385986
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to Long-Term Therapies: Evidence for ActionGeneva, Switzerland2003
   Google Scholar
• IbrahimAREliassonLApperleyJFPoor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapyBlood2011117143733373621346253
   PubMed Web of Science ®Google Scholar
• DarkowTHenkHJThomasSKTreatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemiaPharmacoeconomics200725648149617523753
   PubMed Web of Science ®Google Scholar
• DiMatteoMRVariations in patients’ adherence to medical recommendations: a quantitative review of 50 years of researchMed Care200442320020915076819
   PubMed Web of Science ®Google Scholar
• Ulcickas YoodMOliveriaSAHirjiICzirakyMDavisCAdherence to treatment in patients with chronic myeloid leukemia during a 10-year time period: a medical record reviewProceedings of the 53rd ASH Annual Meeting and ExpositionDecember 10–13, 2011San Diego, CA Abstract 1235
   Google Scholar
• BrecciaMEfficaceFAlimenaGImatinib treatment in chronic myelogenous leukemia: What have we learned so far?Cancer Lett2011300211512121074936
   PubMed Web of Science ®Google Scholar
• StCharlesMBolluVKHornyakECoombsJBlanchetteCMDeAngeloDJPredictors of treatment non-adherence in patients treated with imatinib mesylate for chronic myeloid leukemiaOnline Programs and Abstracts for the 51st ASH Annual Meeting and ExpositionDecember 5–8, 2009New Orleans, LA Abstract 2209
   Google Scholar
• NoensLvan LierdeMADe BockRPrevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO studyBlood2009113225401541119349618
   PubMed Web of Science ®Google Scholar
• de AlmeidaMHPagnanoKBVigoritoACLorand-MetzeIde SouzaCAAdherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a Brazilian single-center cohortActa Haematol20131301162223363706
   PubMed Web of Science ®Google Scholar
• WuEQGuerinAYuAPBolluVKGuoAGriffinJDRetrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemiaCurr Med Res Opin201026122861286921062136
   PubMed Web of Science ®Google Scholar
• KaikkonenPHarsia-AlataloJMedicine reimbursement system and approval of medicine pricesFinnish Statistics on Medicines Finnish Medicines Agency Fimea and Social Insurance InstitutionHelsinki, FinlandEdita Prima Oy20127180
   Google Scholar
• MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)200810534835418453793
   PubMed Web of Science ®Google Scholar
• MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
   PubMed Web of Science ®Google Scholar
• EfficaceFBaccaraniMRostiGInvestigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome studyBr J Cancer2012107690490922871884
   PubMed Web of Science ®Google Scholar
• SartoriusNKuykenWTranslation of health status instrumentsOrleyJKuykenWQuality of Life Assessment: International PerspectivesNew York, NYSpringer Berlin Heidelberg1994319
   Google Scholar
• BaccaraniMDeiningerMWRostiGEuropean LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013Blood2013122687288423803709
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• WagnerJHJusticeACChesneyMSinclairGWeissmanSRodriguez-BarradasMVACS 3 Project Team. Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherenceJ Clin Epidemiol200154Suppl 1S91S9811750214
   PubMed Web of Science ®Google Scholar
• ZellerATaegtmeyerAMartinaBBattegayETschudiPPhysicians’ ability to predict patients’ adherence to antihypertensive medication in primary careHypertens Res20083191765177118971555
   PubMed Web of Science ®Google Scholar
• MortonARiddleRBuchananRKatzDBirchJAccuracy in the prediction and estimation of adherence to bracewear before and during treatment of adolescent idiopathic scoliosisJ Pediatr Orthop200828333634118362800
   PubMed Web of Science ®Google Scholar
• ParkerCSChenZPriceMAdherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE studyJ Gen Intern Med20072291254125917587092
   PubMed Web of Science ®Google Scholar
• TurnerBJHechtFMImproving on a coin toss to predict patient adherence to medicationsAnn Intern Med2001134101004100611352702
   PubMed Web of Science ®Google Scholar
• HorneRWeinmanJBarberNConcordance, Adherence and Compliance in Medicine Taking: Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO)London, UKNational Co-ordinating Centre for NHS Service Delivery and Organisation2005
   Google Scholar